Research and Inspiration of Drug Traceability System in the USA

Abstract

Objective To draw on the experience of the construction and development of drug traceability system in the USA and to provide reference for improving China’s drug traceability system. Methods Literature research and comparative study were used to sort out the background and development of drug traceability system in the USA, including drug traceability code, drug traceability model, drug traceability platform and the application of blockchain technology. On this basis, some suggestions on the construction of drug traceability system in China were put forward. Results and Conclusion The United States has a perfect system of laws and regulations on drug traceability, which encourages the construction of third-party traceability platforms to avoid the formation of monopolies. Besides, the application of blockchain technology in the construction of drug traceability system is also relatively mature. It is suggested that China strengthen the construction of drug traceability system, give play to the advantages of third-party traceability platforms, and improve the application of blockchain technology in drug traceability.

Keywords

drug traceability / drug traceability code / blockchain

References

[1] FDA.Prescription Drug Marketing Act of 1987 [EB/ OL]. (2018-03-29)[2021-04-13]. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/prescription-drug-marketing-act-1987.

[2] Shen Jingyuan, Liang Yi. Research on drug traceability systems at home and abroad under the framework of drug supply chain security[J]. China Pharmaceutical Affairs, 2017, 31 (11): 1263-1269.

[3] Geynisman DM, Wong YN. Drug Supply Chain Security Act and oral anticancer medications: Are we shortchanging our patients?[J]. JAMA Oncology, 2016, 2 (3): 295-296.

[4] FDA. Product identifiers under the drug supply chain security act - questions and answers[EB/OL]. (2018-09-14)[2021-05-07]. https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/productidentifiers-under-drug-supply-chain-security-actquestions-and-answers.

[5] Huang Weiwei, Hua Jia. The inspiration of foreign drug traceability system to China[J]. China Pharmaceutical Affairs, 2016, 30 (12): 1232-1236.

[6] Musamih A, Salah K, Jayaraman R, et al. A blockchainbased approach for drug traceability in healthcare supply chain[J]. IEEE Access, 2021, 9: 9728-9743.

[7] Chen Yongfa, Qi Shu, Gan Jue, et al. The US FDA drug distribution regulatory system (serial II)[J]. China Food and Drug Administration, 2018, 173 (6): 56-62.

[8] Shao Yang, Ma Nengyi. A study on the construction of a feasible system for drug traceability[J]. Shanghai Medicine, 2021, 42 (1): 50-54.

[9] Zhang Tao. Reflections on the establishment of traceability system for drugs, cosmetics and medical devices[J]. Northern Pharmacy, 2020, 17 (5): 179-180.

[10] Hu Zeli. Research on the problems and countermeasures of the construction of drug information tracing system in China[J]. China Pharmacy, 2019, 30 (22): 3025-3029.

[11] Tracelink. Four reasons why pharma companies need a serialization intelligence solution[EB/OL]. (2019-10-02) [2021-05-09]. https://www.tracelink.com/agile-supplychain/resources/four-reasons-why-pharma-companiesneed-a-serialization-intelligence-solution.

[12] Cao Yunchun, Li Tong, Lin Haonan. Research on the construction of drug traceability system based on blockchain technology[J]. Science and Technology Management Research, 2020, 40 (16): 215-224.

[13] Zhang Wenchao, Li Yan. Blockchain technology-based drug traceability scheme[J]. Modern Enterprise, 2019 (9): 58-59.

[14] Prnewswire. Chronicled and the LinkLab announce the MediLedger project, a revolutionary blockchain-backed system to safeguard the pharmaceutical industry [EB/ OL]. (2017-09-21)[2021-05-12]. https://www.prnewswire.com/news-releases/chronicled-and-the-linklab-announcethe-mediledger-project-a-revolutionary-blockchainbacked-system-to-safeguard-the-pharmaceuticalindustry-300522426.html.

[15] Sylim P, Liu F, Marcelo A, et al. Blockchain technology for detecting falsified and substandard drugs in distribution: Pharmaceutical supply chain intervention[J]. JMIR Research Protocols, 2018, 7 (9): e10163.

[16] CoinDesk. Walmart joins pharmaceutical-tracking blockchain consortium MediLedger[EB/OL]. (2019-06-03)[2021-05-12]. https://www.coindesk.com/walmartjoins-pharmaceutical-tracking-blockchain-consortiummediledger.

[17] Lingayat V, Pardikar I, Yewalekar S, et al. Securing pharmaceutical supply chain using blockchain technology[J]. ITM Web of Conferences, 2021, 37: 01013.

[18] PR Newswire. Leaders from 24 companies in the US pharmaceutical supply chain collaborate to submit the “MediLedger DSCSA Pilot Project Final Report” to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs[EB/OL]. (2020-02-21)[2021-06-04]. https://www.prnewswire.com/news-releases/leaders-from-24-companies-in-theus-pharmaceutical-supply-chain-collaborate-to-submitthe-mediledger-dscsa-pilot-project-final-report-to-thefda-proposing-blockchain-for-an-interoperable-track-andtrace-system-for-us-prescription-301008871.html.

[19] Yu Tongxiao, Tian Kan, Zhou Chengyi. Research on drug traceability system under the anti-monopoly perspective[J]. Health Economics Research, 2017 (7): 51-54.

[20] Zhang Yuan, Li Dandan. Exploration on drug traceability code[J]. China Pharmaceutical Affairs, 2020, 34 (11): 1320-1323.

[21] NMPA. Guidelines for the construction of drug informatization traceability system[EB/OL].(2019-04-19)[2021-05-19]. https://www.nmpa.gov.cn/directory/web/nmpa/images/ufq80tKpxre84La9udzA7b7WMjAxOcTqtdozMrrFuau45ri9vP4xLnBkZg=.pdf.

[22] Dong Peng, Qin Xinqiang, Nie Ziqian. Blockchain technology to crack the pain of pharmaceutical traceability[J]. Shanghai Informatization, 2018 (7): 22-25.

[23] Jingdong Science and Technology. Jingdong digital science releases Zhizhen chain pharmaceutical traceability platform to make vaccination more secure[EB/OL]. (2019-11-15)[2021-05-30]. https://baijiahao.baidu.com/s?id=1650258133414475234&wfr=spider&for=pc.

[24] National Development and Reform Commission. Notice of the National Development and Reform Commission on the issuance of the “14th Five-Year Plan” for the development of the bioeconomy[EB/OL]. (2022-05-10)[2022-12-16]. https://www.ndrc.gov.cn/xxgk/zcfb/ghwb/202205/t20220510_1324436.html?code=&state=123.